Doravirine-Islatravir (Idvynso) | National AETC Support Center (NASC)

We'd like your feedback

Was this page helpful?

Yes

No

I found this page helpful because the content on the page:

Check all that apply

Had the information I needed

Was trustworthy

Was up-to-date

Was written clearly

I did not find this page helpful because the content on the page:

Check all that apply

Had too little information

Had too much information

Was confusing

Was out-of-date

Something was broken

Professional discipline

Primary professional discipline

Other reason or comment

Include your email address if you would like a response

Other reason or comment

Include your email address if you would like a response

(Recorded on 06/17/2026)

Access here

Description

Dr. Brian Wood reviews the mechanism of action, clinical trial data, and recommendations for use of the combination tablet doravirine-islatravir for HIV treatment.

Speaker

Brian R. Wood, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington